Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

217,594 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
PIK3R5 genetic predictors of hypertension induced by VEGF-pathway inhibitors.
Quintanilha JCF, Racioppi A, Wang J, Etheridge AS, Denning S, Peña CE, Skol AD, Crona DJ, Lin D, Innocenti F. Quintanilha JCF, et al. Among authors: wang j. Pharmacogenomics J. 2022 Feb;22(1):82-88. doi: 10.1038/s41397-021-00261-5. Epub 2021 Nov 13. Pharmacogenomics J. 2022. PMID: 34775477 Free PMC article.
Bevacizumab-induced hypertension and proteinuria: a genome-wide study of more than 1000 patients.
Quintanilha JCF, Wang J, Sibley AB, Jiang C, Etheridge AS, Shen F, Jiang G, Mulkey F, Patel JN, Hertz DL, Dees EC, McLeod HL, Bertagnolli M, Rugo H, Kindler HL, Kelly WK, Ratain MJ, Kroetz DL, Owzar K, Schneider BP, Lin D, Innocenti F. Quintanilha JCF, et al. Among authors: wang j. Br J Cancer. 2022 Feb;126(2):265-274. doi: 10.1038/s41416-021-01557-w. Epub 2021 Oct 6. Br J Cancer. 2022. PMID: 34616010 Free PMC article. Clinical Trial.
Correction: Bevacizumab-induced hypertension and proteinuria: a genome-wide study of more than 1000 patients.
Quintanilha JCF, Wang J, Sibley AB, Jiang C, Etheridge AS, Shen F, Jiang G, Mulkey F, Patel JN, Hertz DL, Dees EC, McLeod HL, Bertagnolli M, Rugo H, Kindler HL, Kelly WK, Ratain MJ, Kroetz DL, Owzar K, Schneider BP, Lin D, Innocenti F. Quintanilha JCF, et al. Among authors: wang j. Br J Cancer. 2022 Jan;126(1):162. doi: 10.1038/s41416-021-01617-1. Br J Cancer. 2022. PMID: 34853435 Free PMC article. No abstract available.
Genome-wide association studies of survival in 1520 cancer patients treated with bevacizumab-containing regimens.
Quintanilha JCF, Wang J, Sibley AB, Xu W, Espin-Garcia O, Jiang C, Etheridge AS, Ratain MJ, Lenz HJ, Bertagnolli M, Kindler HL, Dickler MN, Venook A, Liu G, Owzar K, Lin D, Innocenti F. Quintanilha JCF, et al. Among authors: wang j. Int J Cancer. 2022 Jan 15;150(2):279-289. doi: 10.1002/ijc.33810. Epub 2021 Oct 5. Int J Cancer. 2022. PMID: 34528705 Free PMC article. Clinical Trial.
More effective nanomedicines through particle design.
Wang J, Byrne JD, Napier ME, DeSimone JM. Wang J, et al. Small. 2011 Jul 18;7(14):1919-31. doi: 10.1002/smll.201100442. Epub 2011 Jun 22. Small. 2011. PMID: 21695781 Free PMC article. Review.
RNA replicon delivery via lipid-complexed PRINT protein particles.
Xu J, Luft JC, Yi X, Tian S, Owens G, Wang J, Johnson A, Berglund P, Smith J, Napier ME, DeSimone JM. Xu J, et al. Among authors: wang j. Mol Pharm. 2013 Sep 3;10(9):3366-74. doi: 10.1021/mp400190z. Epub 2013 Aug 21. Mol Pharm. 2013. PMID: 23924216 Free PMC article.
Rendering protein-based particles transiently insoluble for therapeutic applications.
Xu J, Wang J, Luft JC, Tian S, Owens G Jr, Pandya AA, Berglund P, Pohlhaus P, Maynor BW, Smith J, Hubby B, Napier ME, DeSimone JM. Xu J, et al. Among authors: wang j. J Am Chem Soc. 2012 May 30;134(21):8774-7. doi: 10.1021/ja302363r. Epub 2012 May 17. J Am Chem Soc. 2012. PMID: 22568387 Free PMC article.
217,594 results
You have reached the last available page of results. Please see the User Guide for more information.